Abstract
Systemic corticosteroid is the first-line-treatment for olfactory dysfunction of sinonasal origin but is afflicted with many side-effects. Topic corticosteroid does not reach the same efficacy but has a remarkable safety profile. In this trial we investigated the efficacy of topic therapy with beclomethasone (BDP) –spray. The drug was applied precisely to the olfactory cleft by a special spraying top-part. In addition we determined extinction and volume of a gelaspon sponge placed in the olfactory cleft to show the difference of the topical spray application. 18 patients with anosmia or hyposmia of different genesis and duration applied BDP-spray twice daily for four weeks. The olfactory function was determined using the TDI score (‘Sniffin’-Sticks test battery’). Factors correlated with therapy efficacy were assessed. The median TDI score increased from 13.5 (0–25) at the beginning to 18.5 (1–26) after therapy of four weeks (P = 0.005). The extinction and volume in the moistened sponge was more than two times greater with the top-part than without. The direct application of BDP-spray to the olfactory cleft attained superior therapeutic effects than a usual applied mometasone spray, but did not perform as good as systemic corticosteroid treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ontjes D (1994) Adrenal corticosteroids, corticotrophin releasing hormone, adrenocorticotropin, and anti-adrenal drugs. In: Munson P (ed) Principles of pharmacology. Chapman & Hall, New York, pp 749–788
Meijer OC (2002) Coregulator proteins and corticosteroid action in the brain. J Neuroendocrinol 14:499–505
Blomqvist EH, Lundblad L, Bergstedt H et al (2003) Placebo-controlled, randomized, double-blind study evaluating the efficacy of fluticasone proprionate nasal spray for the treatment of patients with hyposmia/anosmia. Acta Otolaryngol 123:862–868
Heilmann S, Huettenbrink KB, Hummel T (2004) Local and systemic administration of corticosteroids in the treatment of olfactory loss. Am J Rhinol 18:29–33
Benninger MS, Ahmad N, Marple B (2003) The safety of intranasal steroids. Otolaryngol Head Neck Surg 129:739–750
Scheibe M, Bethge C, Witt M et al (2008) Intranasal administration of drugs. Arch Otolaryngol Head Neck Surg 134:643–646
Benninger MS, Hadley JA, Osguthorpe JD et al (2004) Techniques of intranasal steroid use. Otolaryngol Head Neck Surg 130:5–24
Ostwald J, Graumüller S, Dommerich S et al (2003) Influence of rhinologic usual and unusual drugs on fibroblasts from nasal polyps in cell culture. Laryngorhinootologie 82:408–415
Förster G, Damm M, Gudziol H et al (2004) Olfactory dysfunction. Epidemiology, pathophysiological classification, diagnosis and therapy. HNO 52:679–684 Article in German
Heilmann S, Just T, Goektas O et al (2004) Effects of systemic or topical administration of corticosteroids and vitamin B in patients with olfactory loss. Laryngorhinootologie 83:729–734
Hummel T, Sekinger B, Wolf SR et al (1997) Sniffin’ sticks: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold. Chem Senses 22:39–52
Kobal G, Klimek L, Wolfensberger M et al (2000) Multicenter investigation of 1036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds. Eur Arch Ororhinolaryngol 257:205–211
Gudziol V, Lötsch J, Hähner A et al (2006) Clinical significance of results from olfactory testing. Laryngoscope 116:1858–1863
Holm AF, Fokkens PJ (2001) Topical corticosteroids in allergic rhinitis; effects on inflammatory cells and mucosa. Clin Exp Allergy 31:529–535
Lildholdt T, Rundcrantz H, Lindqvist N (1995) Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide. Clin Otolaryngol 20:26–30
Mygind N, Lildholdt T (1996) Nasal polyps treatment: medical management. Allergy Asthma Proc 17:275–282
Stuck BA, Blum A, Hagner AE et al (2003) Mometasone furoate nasal spray improves olfactory performance in seasonal allergic rhinitis. Allergy 58:1195
Hummel T (2000) Perspectives in Olfactory Loss Following Viral Infections of the Upper Respiratory Tract. Arch Otolaryngol Head Neck Surg 126:802–803
Duncan HJ, Seiden AM (1995) Long-term follow-up of olfactory loss secondary to head trauma and upper respiratory tract infection. Arch Otolaryngol Head Neck Surg 121:1183–1187
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fleiner, F., Goktas, O. Topical Beclomethasone in the Therapy of Smelling Disorders—A New Application Technique. Indian J Otolaryngol Head Neck Surg 63, 5–9 (2011). https://doi.org/10.1007/s12070-010-0063-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12070-010-0063-z